Medicare Enrolled

Dr. Thomas O'Connell, MD

Endocrinology · Burlington, NC
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
1234 HUFFMAN MILL ROAD, Burlington, NC 27215
3365381234
In practice since 2006 (19 years)
NPI: 1710047311 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. O'Connell from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. O'Connell? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. O'Connell

Dr. Thomas O'Connell is an endocrinology specialist in Burlington, NC, with 19 years of NPI registration. Based on federal Medicare data, Dr. O'Connell performed 6,308 Medicare services across 1,676 unique beneficiaries.

Between the years covered by Open Payments, Dr. O'Connell received a total of $783,338 from 22 pharmaceutical and/or device companies across 1506 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. O'Connell is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 14% volume in NC $783,338 industry payments

Medicare Practice Summary

Medicare Utilization ↗
6,308
Medicare services
Top 14% in NC for endocrinology
1,676
Unique beneficiaries
$23
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~332 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Denosumab injection (Prolia/Xgeva) 3,960 $18 $27
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
560 $86 $255
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
315 $8 $26
Hemoglobin A1c test (diabetes monitoring)
A blood test that measures your average blood sugar levels over the past two to three months.
304 $9 $54
Thyroid stimulating hormone (TSH) test
A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function.
189 $16 $70
Bone density scan (DEXA)
A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures.
180 $15 $120
Continuous glucose monitoring with interpretation
This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results.
151 $24 $104
Zoledronic acid injection, 1 mg
An injection of zoledronic acid administered at a dose of 1 mg.
100 $7 $186
Basic metabolic blood panel
A blood test that measures a group of basic chemicals, including total calcium levels.
74 $8 $45
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
74 $9 $79
Comprehensive metabolic blood panel
A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers.
60 $10 $47
Lipid panel (cholesterol and triglycerides)
A blood test that measures cholesterol and triglyceride levels.
56 $12 $74
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
47 $128 $344
Ultrasound of head and neck soft tissue
This procedure uses sound waves to create images of the soft tissues in the head and neck area. It allows for the visualization of structures beneath the skin without using radiation.
45 $58 $277
Urine microalbumin test (kidney screening)
A laboratory test that measures the amount of microalbumin, a small protein, in a urine sample. This test is used to detect early signs of kidney damage.
44 $5 $18
Creatinine test (kidney function)
A blood test that measures the amount of creatinine to assess kidney function or detect muscle injury.
44 $5 $18
Free thyroxine (T4) test
A blood test that measures the level of free thyroxine, a thyroid hormone, in the bloodstream.
38 $9 $45
Vitamin B-12 level test
A blood test that measures the amount of vitamin B-12 in your body.
29 $14 $46
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
23 $45 $255
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
15 $59 $172
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.4% high complexity
66.2% medium
33.4% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$783,338
Total received (2018-2024)
Avg $111,905/year across 7 years
Top 2% in NC for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
22
Companies
1,506
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$780,655 (99.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,684 (0.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$112,397
2023
$97,385
2022
$122,244
2021
$62,347
2020
$105,077
2019
$153,052
2018
$130,836

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Insulet Corporation
$38,960
Lilly USA, LLC
$32,364
SANOFI-AVENTIS U.S. LLC
$22,486
Novo Nordisk Inc
$18,186
Abbott Laboratories
$139
Dexcom, Inc.
$95
Radius Health, Inc.
$52
Ancora Heart, Inc.
$37
Boehringer Ingelheim Pharmaceuticals, Inc.
$28
Ascensia Diabetes Care Us Inc.
$19
Xeris Pharmaceuticals, Inc.
$18
CeQur Corporation
$14
Top 3 companies account for 83.5% of 2024 payments
All-time payments by company (2018-2024) ›
Lilly USA, LLC
$385,185
Novo Nordisk Inc
$263,350
SANOFI-AVENTIS U.S. LLC
$58,580
Insulet Corporation
$39,895
Boehringer Ingelheim Pharmaceuticals, Inc.
$16,900
AstraZeneca Pharmaceuticals LP
$11,319
Merck Sharp & Dohme Corporation
$6,978
Abbott Laboratories
$334
Dexcom, Inc.
$265
MannKind Corporation
$128
Radius Health, Inc.
$80
Shire North American Group Inc
$63
Medtronic MiniMed, Inc.
$54
Ancora Heart, Inc.
$37
Xeris Pharmaceuticals, Inc.
$30
Mannkind Corporation
$30
CeQur Corporation
$27
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$24
Ascensia Diabetes Care Us Inc.
$19
Tandem Diabetes Care, Inc.
$15
Acella Pharmaceuticals, LLC
$14
Ascendis Pharma Inc
$13
Top 3 companies account for 90.3% of all-time payments
Associated products mentioned in payments ›
AFREZZA · AccuCinch · BASAGLAR · BYDUREON · CeQur Simplicity · DIABETES - DISEASE · Dexcom CGM · Dexcom G6 Transmitter · EVERSENSE E3 SENSOR KIT - RETAIL · FARXIGA · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre 2 · GVOKE HYPOPEN · HUMULIN · JANUVIA · JARDIANCE · Levemir · MOUNJARO · Minimed 670G System · NATPARA (PARATHYROID HORMONE) · NP Thyroid 60 · Omnipod · Ozempic · RECORLEV · RYBELSUS · Rybelsus · SOLIQUA · SOLIQUA 100/33 · Saxenda · TOUJEO · TRULICITY · TZIELD · Tresiba · Tymlos · Victoza · Wegovy · XIFAXAN · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (100%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in endocrinology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for endocrinology in NC.

Looking for an endocrinology specialist in Burlington?
Compare endocrinologists in the Burlington area by procedure volume, costs, and industry payment transparency.
Browse endocrinologists nearby

Geographic Context

Endocrinologists within 10 mi
12
Per 100K population
6.9
County median income
$64,445
Nearest hospital
MOSES H. CONE MEMORIAL HOSPITAL, THE
14.6 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. O'Connell is a mixed practice specialist, with above-average Medicare volume (top 14% in NC), with speaking/promotional industry engagement in the top 2% of NC peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. O'Connell experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. O'Connell performed 3,960 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. O'Connell receive payments from pharmaceutical companies?
Yes. Dr. O'Connell received a total of $783,338 from 22 companies across 1,506 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. O'Connell's costs compare to other endocrinologists in Burlington?
Dr. O'Connell's average Medicare payment per service is $23. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. O'Connell) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →